Plus Therapeutics Inc (PSTV)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -60.979 | -80.524 | -54.386 | -48.458 | -46.646 | -78.619 | -88.444 | -75.541 |
Return on Equity (%) | -190.117 | -222.321 | -165.937 | -358.371 | -393.271 | -193.25 | -234.651 | -522.503 |
Return on Invested Capital (%) | -81.87 | -129.241 | -166.516 | -143.161 | -466.261 | -131.911 | -151.375 | -301.414 |
Operating Margin (%) | -417.826 | -767.46 | -291.801 | -20.406 | -2354.455 | N/A | -8733.929 | -262.996 |
Net Profit Margin (%) | -473.497 | -991.558 | -411.904 | -163.49 | -2719.802 | N/A | -9051.339 | -271.036 |
Book Value Per Share | -0.064 | 0.032 | -0.29 | 0.155 | 0.324 | 0.671 | 0.178 | -0.389 |
Earnings Per Share | -1.015 | -0.461 | -0.943 | -2.25 | -1.036 | -0.864 | -0.603 | -2.943 |
Cash Per Share | 0.578 | 0.165 | 0.328 | 3.452 | 1.05 | 1.186 | 0.539 | 1.89 |
Working Capital Per Share | 0.288 | -0.061 | -0.493 | 1.05 | 0.08 | 0.893 | 0.297 | -0.197 |
Operating Profit Per Share | 0.459 | 0.104 | 0.395 | 1.376 | 0.038 | N/A | 0.007 | 1.086 |
EBIT Per Share | -1.015 | -0.392 | -0.788 | -0.646 | -1.036 | -0.864 | -0.603 | -2.943 |
EBITDA Per Share | -1.015 | -0.392 | -0.788 | -0.646 | -1.036 | -0.864 | -0.603 | -2.943 |
Free Cash Flow Per Share | -1.072 | -0.493 | -1.063 | -2.413 | -1.025 | -0.88 | -0.599 | -3.046 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 21,71M | 57,86M | 14,83M | 3,88M | 6,75M | 15,51M | 33,6M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 33,6M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -923.123 | N/A | N/A | N/A | -192.427 | N/A | N/A |
Net Profit Margin (%) | N/A | -949.605 | N/A | N/A | N/A | -194.454 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 7,96M |
Ratio cours/bénéfice | -0,59 |
Ratio prix/ventes | 1,6 |
Ratio prix/liquidités | 0,92 |
Ratio prix/valeur comptable | -5,82 |
Rendement de dividende | - |
Actions en circulation | 5,9M |
Volume moyen (1 semaine) | 55,52k |
Volume moyen (1 mois) | 94,44k |
Variation sur 52 semaines | -39,58% |
Plus haut sur 52 semaines | 2,6702 |
Plus bas sur 52 semaines | 1,12 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales